Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy

被引：0
|
作者：
Giovanni Fucà
Giulia Galli
Marta Poggi
Giuseppe Lo Russo
Claudia Proto
Martina Imbimbo
Milena Vitali
Monica Ganzinelli
Claudia Lanti
Giuliano Molino
Fabiano Stangoni
Nicoletta Zilembo
Filippo de Braud
Marina Chiara Garassino
Diego Signorelli
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Medical Oncology Department
[2] University of Milan,Department of Oncology and Hemato
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：795 / 800
页数：5
相关论文
共 50 条
  • [21] Clinical characteristics and outcomes of patients with EGFR mutated non-small cell lung cancer treated by EGFR targeted therapy then immunotherapy
    Hazim, Antonious
    Xiao, Alexander
    Smith, Caleb
    Dimou, Anastasios
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E10 - E10
  • [22] The Influence of Serum Sodium Concentration on Prognosis in Resected Non-Small Cell Lung Cancer
    Kobayashi, Naohiro
    Usui, Shingo
    Yamaoka, Masatoshi
    Suzuki, Hisashi
    Kikuchi, Shinji
    Goto, Yukinobu
    Sakai, Mitsuaki
    Sato, Yukio
    THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (04): : 338 - 343
  • [23] Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy
    Hendriks, Lizza E.
    Rouleau, Etienne
    Besse, Benjamin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 647 - 660
  • [24] A retrospective review of clinical predictors of outcomes of immunotherapy in metastatic non-small cell lung carcinoma
    Ding, T. -E.
    Mackean, M.
    Barrie, C.
    Phillips, I.
    LUNG CANCER, 2020, 139 : S59 - S59
  • [25] Real World Outcomes after Chemotherapy and Immunotherapy in Patients with Metastatic Non-Small Cell Lung Cancer in Europe
    Leal, T.
    Dasgupta, A.
    Latremouille-Viau, D.
    Yang, M.
    Hu, X.
    Liu, S.
    Barlesi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S632 - S632
  • [26] A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer
    Lu, Ping
    Ma, Yifei
    Kai, Jindan
    Wang, Jun
    Yin, Zhucheng
    Xu, Hongli
    Li, Xinying
    Liang, Xin
    Wei, Shaozhong
    Liang, Xinjun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [27] Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer
    McKinley, Blake
    Li, Shenduo
    Wiest, Nathaniel
    Butts, Emily
    Pai, Tanmayi
    Wang, Jing
    Mosalem, Osama M.
    Correia, Guilherme Sacchi de Camargo
    Patel, Jaydeepbhai
    Koshiya, Hiren
    Inampudi, Jyothik Varun
    Zhao, Yujie
    Manochakian, Rami
    Lou, Yanyan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy era
    Zhang, David
    Rohatgi, Anjali
    CANCER, 2025, 131 (01)
  • [29] Clinical determinants of immunotherapy outcomes in non-small cell lung cancer patients with checkpoint inhibitor pneumonitis
    Vathiotis, I
    Tavernaraki, K.
    Trontzas, I
    Antonogiannaki, E.
    Koukaki, E.
    Syrigos, N.
    Gkiozos, I
    Kotteas, E.
    Charpidou, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] Low pre-immunotherapy forced vital capacity is associated with poor outcomes in non-small cell lung cancer patients receiving immunotherapy regardless of prior treatment history
    Lim, Jeong Uk
    Kang, Hye Seon
    Yeo, Chang Dong
    Kim, Ju Sang
    Kim, Sung Kyoung
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345